DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alnylam Pharmaceuticals, Inc. (ALNY)
« Back to company indexALNY Chatter Timeline
Stock Ticker for ALNY
Most Active Tweeters for ALNY
| User | Tweets |
|---|---|
| @Gambiste1 | 11 |
| @AmericanBanking | 8 |
| @newsfilterio | 6 |
| @dailypoliticaln | 5 |
| @TheMarketsDaily | 5 |
Recent Tweets for ALNY
 |
@TheMarketsDaily Alnylam Pharmaceuticals $ALNY Raised to Strong-Buy at BidaskClub https://t.co/g4MDB3hpQY December 7th 2019, 7:12am |
 |
@EnterpriseLeade Alnylam Pharmaceuticals $ALNY Upgraded by BidaskClub to Strong-Buy https://t.co/D5eMRJQHfo December 7th 2019, 7:12am |
 |
@TickerReport $71.27 Million in Sales Expected for Alnylam Pharmaceuticals, Inc. $ALNY This Quarter https://t.co/9UNCZcvWoA December 7th 2019, 4:12am |
 |
@dailypoliticaln Analysts Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Quarterly Sales of $71.27 Million https://t.co/wGexBGYzA4 December 7th 2019, 4:12am |
 |
@AmericanBanking $71.27 Million in Sales Expected for Alnylam Pharmaceuticals, Inc. $ALNY This Quarter https://t.co/Q8AqAGmLDU #stocks December 7th 2019, 4:12am |
|
@AmericanBanking Alnylam Pharmaceuticals, Inc. $ALNY Given Consensus Recommendation of “Buy” by Brokerages https://t.co/6jye35Of9C #stocks December 6th 2019, 2:12pm |
 |
@WeekHerald Alnylam Pharmaceuticals, Inc. $ALNY Given Average Rating of “Buy” by Analysts https://t.co/2JXHEAd9Qw December 6th 2019, 2:12pm |
 |
@OlympiaReport Alnylam Pharmaceuticals, Inc. $ALNY Given Consensus Recommendation of “Buy” by Brokerages https://t.co/nzqxi3EHLN December 6th 2019, 2:12pm |
 |
@intercooleronli Alnylam Pharmaceuticals $ALNY Rating Increased to Strong-Buy at BidaskClub https://t.co/6bYKgveiaa #investingnews December 6th 2019, 4:12am |
 |
@ledgerzette Alnylam Pharmaceuticals $ALNY Rating Increased to Strong-Buy at BidaskClub https://t.co/Q9f7RxJuHt #stocks December 6th 2019, 4:12am |
|
@AmericanBanking Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$2.11 Per Share https://t.co/NzlQzL1Y7K #stocks December 5th 2019, 5:12pm |
 |
@ZolmaxNews Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$2.11 Per Share https://t.co/j8Vsmpyb4V December 5th 2019, 5:12pm |
|
@dailypoliticaln Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$2.11 Per Share https://t.co/m1iNbqO7Ji December 5th 2019, 5:12pm |
 |
@StckPro $ALNY NEW ARTICLE : Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow https://t.co/RIsluTR97l Get al… https://t.co/PIqrZVUUTR December 5th 2019, 3:12pm |
 |
@SeekingAlpha $ALNY - Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow. Read more and get updates on any stock!… https://t.co/j63aaoji63 December 5th 2019, 3:12pm |
 |
@9parvin9 $ALNY Hey Mark get back to work. Lol December 5th 2019, 3:12pm |
|
@WeekHerald Alnylam Pharmaceuticals $ALNY Upgraded to Strong-Buy at BidaskClub https://t.co/de4APTLnh3 December 5th 2019, 11:12am |
|
@OlympiaReport Alnylam Pharmaceuticals $ALNY Upgraded to Strong-Buy by BidaskClub https://t.co/nOOuLB5PpY December 5th 2019, 11:12am |
 |
@SwingTradeBot New 52 Week High today: $ALNY ... https://t.co/4Iw0QeR3p8 December 5th 2019, 10:12am |
 |
@IonisDisrupts @Jessicaemerrill See $alny game plan. #onpattro December 5th 2019, 10:12am |
 |
@fda_tracker $ALNY Phase 3 trial w/est Dec completion date NCT03681184: https://t.co/XCurHX4WBz Trial Tracker: https://t.co/aR7q5orVrP December 5th 2019, 9:12am |
|
@StckPro $ALNY NEW ARTICLE : Alnylam Continues To Deliver On RNAi Pipeline With Alternative Treatment Option For Rare Diseas… https://t.co/TCcOv540HO December 4th 2019, 7:12pm |
|
@SeekingAlpha $ALNY - Alnylam Continues To Deliver On RNAi Pipeline With Alternative Treatment Option For Rare Disease. Subscribe… https://t.co/ea6trwyhC8 December 4th 2019, 7:12pm |
|
@StckPro $ALNY NEW ARTICLE : Why Has Alnylam’s Stock Gained 25% In The Last Two Weeks https://t.co/3S7GxM8Uc8 Get all the la… https://t.co/YtQ6clZs08 December 4th 2019, 1:12pm |
|
@SwingTradeBot New 52 Week High today: $ALNY $IMKTA ... https://t.co/4Iw0QeR3p8 December 4th 2019, 12:12pm |
 |
@kirklsp @3IDWarrant @RNAiAnalyst Well, sort of. Much but not all was licensed. Royalty rights related to $ALNY were kept an… https://t.co/mRFyLidHUN December 4th 2019, 11:12am |
 |
@newsfilterio The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug $IBB $ALNY… https://t.co/Qr3xdbTApq December 4th 2019, 7:12am |
 |
@WatchlistN Alnylam Pharmaceuticals $ALNY Upgraded to Strong-Buy at BidaskClub https://t.co/exhBcMajiD December 4th 2019, 3:12am |
|
@TickerReport BidaskClub Upgrades Alnylam Pharmaceuticals $ALNY to Strong-Buy https://t.co/PrUbpoozd4 December 4th 2019, 3:12am |
 |
@IncredibleTrade $ALNY worth watch. #ibd https://t.co/W4OTtWuGVZ December 3rd 2019, 11:12pm |
 |
@JorelLaraKalel Does a Surprise Approval Make Alnylam Pharmaceuticals a Buy? $ALNY https://t.co/q5ZbscLcdw December 3rd 2019, 10:12pm |
|
@AmericanBanking Alnylam Pharmaceuticals $ALNY – Analysts’ Recent Ratings Updates https://t.co/7A2a9qcu97 #stocks December 3rd 2019, 6:12pm |
 |
@ThisLincolnian Alnylam Pharmaceuticals $ALNY – Analysts’ Recent Ratings Updates https://t.co/fSoGTi5GdK December 3rd 2019, 6:12pm |
 |
@MC_OptionTrades $ALNY 20-Dec-19 Straddle Implies a ±8.4% move. Dec 4 Evercore ISI 2nd Annual HealthCONx Conference https://t.co/guU4GWiQ50 December 3rd 2019, 4:12pm |
|
@ZolmaxNews Alnylam Pharmaceuticals $ALNY Sets New 12-Month High at $120.62 https://t.co/24E3EBDP2e December 3rd 2019, 3:12pm |
|
@dailypoliticaln Alnylam Pharmaceuticals $ALNY Sets New 52-Week High at $120.62 https://t.co/o1RovGvqkv December 3rd 2019, 3:12pm |
 |
@MSS1992BIO Looking at $alny https://t.co/b7eN5zedsK December 3rd 2019, 2:12pm |
|
@StckPro $ALNY NEW ARTICLE : Here's Why Alnylam Pharmaceuticals Rose 35.1% in November https://t.co/50d1u2AbCK Get all the l… https://t.co/yW7c8xoKUT December 3rd 2019, 2:12pm |
 |
@cheesetrader1 $ALNY don't care 'bout your bear market December 3rd 2019, 11:12am |
|
@StckPro $ALNY NEW ARTICLE : Does a Surprise Approval Make Alnylam Pharmaceuticals a Buy? https://t.co/yAQ53aDll4 Get all th… https://t.co/zOEJadO5ls December 3rd 2019, 10:12am |
 |
@fpscod9 $ARWR We are following $ALNY offering playbook, EXCEPT, we got much better CLINICAL DATA. ? December 2nd 2019, 4:12pm |
 |
@happyycamperr oh will be interesting to see which Bio "Hidey Holes" they try to create! $ALNY December 2nd 2019, 10:12am |
 |
@Psoriasischamp RT @megtirrell: FDA approves $ALNY's givosiran (Givlaari) for acute hepatic porphyria: https://t.co/3x154wcVPV PDUFA date on drug was Feb… December 1st 2019, 11:12am |
 |
@Bu_LLss $ALNY waiting for a better entry. I love this stock with a huge potential... Also Buyout candidate December 1st 2019, 10:12am |
|
@OlympiaReport Alnylam Pharmaceuticals $ALNY Given New $159.00 Price Target at Cantor Fitzgerald https://t.co/N74LMv2VlA December 1st 2019, 9:12am |
 |
@Gambiste1 RT @newsfilterio: 9,999 shares acquired by Greene Barry E (President), form 4 filed with the SEC $ALNY https://t.co/lV8VepZ6EZ November 30th 2019, 3:11am |
|
@Gambiste1 RT @newsfilterio: 17,498 shares acquired by Maraganore John (Chief Executive Officer), form 4 filed with the SEC $ALNY https://t.co/XIQCUB… November 30th 2019, 3:11am |
|
@dailypoliticaln Oppenheimer Comments on Alnylam Pharmaceuticals, Inc.’s Q1 2020 Earnings $ALNY https://t.co/EdzXHkmLt9 November 30th 2019, 1:11am |
|
@TickerReport Oppenheimer Comments on Alnylam Pharmaceuticals, Inc.’s Q1 2020 Earnings $ALNY https://t.co/vb7ki2bxvW November 30th 2019, 1:11am |
|
@newsfilterio 9,999 shares acquired by Greene Barry E (President), form 4 filed with the SEC $ALNY https://t.co/lV8VepZ6EZ November 30th 2019, 12:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.